| Primary |
| Pain |
21.7% |
| Cholecystitis |
5.8% |
| Dyspnoea |
5.8% |
| Hypertension |
5.8% |
| Lung Neoplasm Malignant |
5.8% |
| Musculoskeletal Pain |
5.8% |
| Neuralgia |
5.8% |
| Pain In Extremity |
5.8% |
| Trigeminal Neuralgia |
5.8% |
| Sickle Cell Anaemia |
4.3% |
| Antiplatelet Therapy |
2.9% |
| Breast Cancer Metastatic |
2.9% |
| Constipation |
2.9% |
| Gout |
2.9% |
| Haemoglobin Decreased |
2.9% |
| Increased Viscosity Of Bronchial Secretion |
2.9% |
| Muscle Spasms |
2.9% |
| Myofascial Pain Syndrome |
2.9% |
| Thyroid Disorder |
2.9% |
| Analgesia |
1.4% |
|
| Completed Suicide |
14.8% |
| Drug Abuse |
11.1% |
| Respiratory Arrest |
9.3% |
| Death |
7.4% |
| Overdose |
7.4% |
| Drug Toxicity |
5.6% |
| Sedation |
5.6% |
| Sickle Cell Anaemia |
5.6% |
| Accidental Overdose |
3.7% |
| Memory Impairment |
3.7% |
| Somnolence |
3.7% |
| Swollen Tongue |
3.7% |
| Transient Ischaemic Attack |
3.7% |
| Unresponsive To Stimuli |
3.7% |
| Cardiac Arrest |
1.9% |
| Circumstance Or Information Capable Of Leading To Medication Error |
1.9% |
| Deafness |
1.9% |
| Drug Ineffective |
1.9% |
| Drug Prescribing Error |
1.9% |
| Haemodynamic Instability |
1.9% |
|
| Secondary |
| Product Used For Unknown Indication |
31.0% |
| Drug Use For Unknown Indication |
15.3% |
| Pain |
14.0% |
| Abdominal Pain |
9.2% |
| Depression |
5.9% |
| Analgesia |
2.5% |
| Parkinson's Disease |
2.4% |
| Laxative Supportive Care |
2.1% |
| Constipation |
1.8% |
| Analgesic Therapy |
1.7% |
| Non-small Cell Lung Cancer |
1.7% |
| Prophylaxis Of Nausea And Vomiting |
1.7% |
| Tumour Pain |
1.7% |
| Breast Cancer |
1.6% |
| Insomnia |
1.4% |
| Multiple Myeloma |
1.4% |
| Malaise |
1.3% |
| Prophylaxis |
1.3% |
| Rheumatoid Arthritis |
1.1% |
| Cholecystitis |
0.8% |
|
| Abdominal Pain |
26.4% |
| Cardio-respiratory Arrest |
15.5% |
| Multiple Drug Overdose |
7.8% |
| Pain |
6.2% |
| Miosis |
5.4% |
| Death |
3.9% |
| Renal Failure Acute |
3.9% |
| Vomiting |
3.9% |
| Drug Toxicity |
3.1% |
| Pollakiuria |
3.1% |
| White Blood Cell Count Increased |
3.1% |
| Lethargy |
2.3% |
| Overdose |
2.3% |
| Respiratory Arrest |
2.3% |
| Respiratory Depression |
2.3% |
| Swollen Tongue |
2.3% |
| Confusional State |
1.6% |
| Constipation |
1.6% |
| Depression |
1.6% |
| Drug Withdrawal Syndrome |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.1% |
| Drug Use For Unknown Indication |
17.3% |
| Pain |
16.8% |
| Crohn's Disease |
4.9% |
| Constipation |
4.7% |
| Nausea |
4.2% |
| Non-small Cell Lung Cancer |
3.9% |
| Prophylaxis |
3.7% |
| Multiple Myeloma |
3.5% |
| Analgesic Therapy |
3.3% |
| Hypertension |
2.4% |
| Acute Myeloid Leukaemia |
2.4% |
| Rheumatoid Arthritis |
1.9% |
| Breast Cancer |
1.5% |
| Diabetes Mellitus |
1.5% |
| Depression |
1.5% |
| Insomnia |
1.4% |
| Antifungal Prophylaxis |
1.4% |
| Rhabdomyosarcoma |
1.4% |
| Anxiety |
1.3% |
|
| Vomiting |
16.0% |
| Renal Failure Acute |
6.8% |
| Death |
5.8% |
| Pain |
5.8% |
| Thrombocytopenia |
5.5% |
| Weight Decreased |
5.5% |
| Inhibitory Drug Interaction |
5.1% |
| Nausea |
5.1% |
| Pyrexia |
4.4% |
| Vision Blurred |
4.4% |
| Upper Gastrointestinal Haemorrhage |
4.1% |
| Weight Increased |
4.1% |
| Hypercalcaemia |
3.8% |
| Neutropenia |
3.8% |
| Somnolence |
3.8% |
| Pneumonia |
3.4% |
| Sepsis |
3.4% |
| Drug Interaction |
3.1% |
| Pancytopenia |
3.1% |
| Premature Baby |
3.1% |
|
| Interacting |
| Pain |
84.4% |
| Postoperative Care |
9.4% |
| Product Used For Unknown Indication |
6.3% |
|
| White Blood Cell Count Increased |
44.4% |
| Stevens-johnson Syndrome |
33.3% |
| Respiratory Arrest |
22.2% |
|
